Micro cap Marinus Pharmaceuticals was up 20% premarket this morning on positive, early data from its midstage test of ganaxolone in a rare condition that…

PixarBio has scrapped its bid to buy InVivo Therapeutics “for reasons related to management credibility and competence, corporate governance and IP control.”

Just months after writing off a cholesterol drug, Catabasis is back with the first data on its Duchenne muscular dystrophy candidate.

Cytori Therapeutics is set to gain cancer drugs and a liposomal nanoparticle technology platform through the acquisition of Azaya Therapeutics.

Global pharma chief Hussain joins a long list of departing execs at GSK, Merrimack taps Sanofi Genzyme SVP Dr. Richard Peters as CEO, and ex-GSK rare disease…

From video game-based therapies and a liquid biopsy for cancer to deep learning and bioelectronics, 2016’s Fierce 15 are redefining what it means to be a…

Immunomedics says new data for lead drug IMMU-132 in triple-negative breast cancer keep it on course to file for accelerated approval in mid-2017.

In this week's EuroBiotech Report, Evotec co-founds startup, ObsEva sets terms for IPO, U.K. heads for hard Brexit and more.

Biotech